Story Navigation
-
DiscoveryBiomedical ResearchCell and Gene TherapyGenetic DiseaseNeurodegenerative DiseaseNeuroscience
Addressing unmet needs for inherited neuromuscular diseases
Novartis has acquired Kate Therapeutics to further enhance and strengthen our ongoing efforts to advance gene therapies for patients.
Discovery -
People and Culture / CareersCareersInnovationReimagine MedicineDigitalWorking at Novartis
My Journey to Novartis: Finding my Purpose and Passion
When I first joined Novartis, I was nervous yet open to new experiences. I did not have experience in the pharmaceutical industry, and the dynamics and ways of working in marketing were completely different from what I was used to. But what sealed the deal for me was a conversation with my then manager who told me that the purpose I would feel and impact I would have would be unique. And she was right.
People and CultureCareers -
Access to HealthcareNovartis AccessHeart FailureAccess to Healthcare
Negative impact of the IRA on patient access to innovative treatments
At Novartis, we are constantly pushing the limits of science to develop and deliver transformative medicines that fight disease and help people live life on their terms.
Access to Healthcare -
People and CultureCareersSocial CommitmentWorking at Novartis
Every number has a story – my journey to Novartis as a Refugee
The current refugee crisis is one of the world's greatest humanitarian challenges. Svitlana shares her story of her journey to Novartis and how her work as part of the Giving and Volunteering team is opening the doors to refugees and other marginalized groups and allowing our people to make a difference by helping those who are most vulnerable.
People and Culture -
People and CultureCareersInnovationLocal ImpactSocial CommitmentWorking at Novartis
Is Diversity, Equity and Inclusion (DEI) really that important?
We think so and here are just some of the reasons why: we believe our workplace should reflect today’s emerging workforce; every culture needs diversity to thrive; and it supports fair treatment and opportunities for all our people.
People and Culture -
DiscoveryBiomedical ResearchCancerClinical Research
A legacy of blood cancer innovation
Building on more than two decades of chronic myeloid leukemia research, the R&D teams at Novartis pursued an investigational treatment unlike any other.
Discovery -
People and CultureBiomedical ResearchCareersWomen in ScienceDrug DiscoveryWorking at Novartis
A personal journey full circle, from curiosity about life on Earth to transformative therapies at Novartis
From curiosity about life on Earth to transformative therapies at Novartis. Michelle L Krishnan, Executive Director, MD PhD.
People and Culture -
People and CultureCareersEmerging TechnologyFuture of HealthcareInnovationWorking at Novartis
From black holes to AI driven drug discovery – collaboration wins the day
Dr Bülent Kızıltan, Global Head of AI & Computational Sciences
People and Culture -
From Our LabsCancerDrug DevelopmentOncologyReimagine MedicineTargeted Therapy
Drug delivery, service delivery, and the future of cancer care
State-of-the-art Novartis manufacturing facility in Indianapolis fortifies the foundation of an entirely new paradigm in pharmaceutical drug delivery.
From Our Labs -
Patient PerspectivesPatient VoicesOncologyCancerClinical Trials
Listening to the CML patient community
Improving the patient experience and removing potential barriers to clinical trial participation
Patient Perspectives -
People and CultureWorking at NovartisBiomedical ResearchData ScienceDrug DiscoveryGene Testing
How collaboration can enhance your science career
Kumar Veerapen, Senior Expert I Data Science
People and Culture -
Patient PerspectivesCancerOncologyDisease AwarenessLiving With DiseasePatient Voices
Facing the fear of breast cancer recurrence
When Laurie Brunner found a lump in her breast just before Thanksgiving in 2018, it was the beginning of one of the most difficult periods of her life. Although treatment put her cancer into remission, she found herself dealing with an emotional toll that affects many survivors of early-stage breast cancer: the fear of it coming back.
Photos: Brent Stirton, Getty Images for Novartis
Patient Perspectives
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 32
- › Next page